Related Experiment Videos
[Different forms of drug therapy for progressive sensorineural hearing loss in childhood]
A Nickisch1, M Heinemann, M Gross
1Klinik für Kommunikationsstörungen, Johannes-Gutenberg-Universität Mainz.
Insights
This study investigated a 10-day treatment for progressive sensorineural hearing loss in young patients using prednisolone, pentoxifylline, and piracetam. The combination therapy showed a 58% improvement in auditory thresholds, with no significant difference compared to previous treatments lacking piracetam.
Area of Science:
- Otolaryngology
- Neuroscience
- Pharmacology
Context:
- Progressive sensorineural hearing loss (SNHL) affects individuals across a wide age range, impacting auditory function.
- Pediatric SNHL presents unique challenges in management and treatment efficacy.
- Identifying effective therapeutic strategies for SNHL is crucial for preserving hearing and quality of life.
Purpose:
- To evaluate the efficacy of a 10-day infusion treatment combining prednisolone, pentoxifylline, and piracetam in pediatric and adolescent patients with progressive sensorineural hearing loss.
- To compare the treatment outcomes with a previous therapeutic regimen involving prednisolone and pentoxifylline, but excluding piracetam.
Summary:
- Twenty-six patients aged 2 to 19 years with progressive SNHL received a 10-day course of intravenous prednisolone, pentoxifylline, and piracetam.
- Auditory thresholds improved in 58% of patients following this combined therapy.
- No statistically significant difference in treatment efficacy was observed when compared to a prior study using prednisolone and pentoxifylline without piracetam.
Impact:
- This research contributes to understanding potential pharmacological interventions for pediatric sensorineural hearing loss.
- The findings suggest that the addition of piracetam to prednisolone and pentoxifylline may not offer a significant advantage over the existing treatment for this condition.
- Further research may be warranted to explore alternative or adjunctive therapies for progressive SNHL in young individuals.
Abstract:
Because of progressive sensorineural hearing loss 26 patients of the age of 2 to 19 years were treated for 10 days with infusions of prednisolone, pentoxifylline and piracetam. After this treatment improved, auditory thresholds were found in 58%. In comparison with a previous investigation (treatment with prednisolone and pentoxifylline except piacetam), no significant difference between these two methods of therapy was seen.